Discussion

• @andrewe_dunn Andrew Dunn on x

  All of a sudden, it's a crowded space of tech players looking to work with and sell to biopharma OpenAI's GPT-Rosalind Nvidia's BioNeMo Anthropic's Claude for Life Sci AWS' Amazon Bio Discovery (launched earlier this week) Edison Scientific Phylo & more that I'm surely missing

• @andrewe_dunn Andrew Dunn on x

  NEW: OpenAI is the latest tech giant to move into biopharma, launching Thursday GPT-Rosalind, a life sciences-tailored version of its LLM Trails behind the very similar launch of Anthropic's Claude for Life Sciences by ~5 months. More here: https://endpoints.news/...

• @gdb Greg Brockman on x

  Announcing GPT-Rosalind, our frontier model for life science research. This model is a step towards one of our most important goals — accelerating science and improving human outcomes. Excited to work with many amazing partners on deploying and improving this model. [image]

• @deanwball Dean W. Ball on x

  It is also interesting that OpenAI is de-emphasizing safety concerns here, not mentioned at all in the tweets and only lightly discussed in the blog post. One imagines that if Anthropic had trained a similar model, they'd be way more “risk-forward.” It's not obvious to me which

• @deanwball Dean W. Ball on x

  Available to “qualified customers.” As I wrote after Mythos, expect more models to have staggered releases, often exclusive to large firms and governments at first, due to a combination of safety reasons (biorisk in this case) and compute constraints.

• @sporadica @sporadica on x

  i like it when the big labs release tools specifically for accelerating scientific research, instead of just more addictive chatbots good release

• @bowang87 Bo Wang on x

  It is clear that every frontier AI lab will have dedicated frontier models for biology and drug discovery 🔥 Great time to be working on AI &Bio ! Can't wait to see what GPT-Rosalind can unlock for drug discovery!

• r/singularity r on reddit

  Introducing GPT-Rosalind for life sciences research